Neurocrine Bioscience buy Oppenheimer Holdings Inc.
Start price
24.04.24
/
50%
€134.95
Target price
24.04.25
€187.12
Performance (%)
-0.30%
Price
24.07.24
€134.55
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by -0.30%. This prediction currently runs until 24.04.25. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.701% | 1.701% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $200.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€133.55
02.05.24
02.05.24
€201.87
02.05.25
02.05.25
0.75%
24.07.24
24.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€128.35
18.03.24
18.03.24
€183.92
18.03.25
18.03.25
4.83%
24.07.24
24.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
42.23%
24.07.24
24.07.24